MicrosoftTeams-image (5).png
Inotropic Agents Market Value to Surpass US$ 5.1 Bn by 2031: TMR Study
07 mars 2023 14h30 HE | Transparency Market Research
Wilmington, Delaware, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – As per a TMR study, the Inotropic Agents Market was valued at US$ 1.9 Bn in 2022 and is...
PharmAla Biotech Logo 800 x 422.png
PharmAla Biotech Closes Purchase Order With Emyria Ltd., Completes Filing of “LaNeo” Trademark in Australia
14 févr. 2023 08h00 HE | PharmAla Biotech
VANCOUVER, British Columbia, Feb. 14, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) is pleased to announce that, in the wake of a landmark decision by the...
visiongain Logo.png
Allergic rhinitis drugs market is projected to grow at a CAGR of 3.78% by 2033: Visiongain Reports Ltd
03 févr. 2023 11h54 HE | Visiongain Reports Ltd
Visiongain has published a new report entitled Allergic Rhinitis Drugs Market Report 2023-2033. It includes profiles of Allergic Rhinitis Drugs Market and Forecasts, Market Segment by Size by...
Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change
03 févr. 2023 00h01 HE | PharmAla Biotech
VANCOUVER, British Columbia, Feb. 03, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for...
Persistence Market Research
High Potency Active Pharmaceutical Ingredients Market to Reach a Revenue of Around US$ 23.3 Billion by the End of 2023 at a CAGR of 11.1%, States Persistence Market Research 
02 févr. 2023 09h30 HE | Persistence Market Research
New York, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The High-potency pharmaceutical active ingredients market revenues were estimated at US$ 21.2 Billion in 2022 and is anticipated to grow at a CAGR of...
PharmAla Biotech Logo 800 x 422.png
PharmAla Biotech granted an Export Permit for 300 grams of LaNeo™ MDMA
24 janv. 2023 08h50 HE | PharmAla Biotech
VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE: MDMA), a biotechnology company focused on the research, development, and...
DI 400 x 400  copy jpeg.jpg
Pharmaceutical Drugs Market by 2022-2027 | Demand, Trends, Opportunities, Challenges, Risks Factors Analysis, Competitive Situation | Key Players, Types, Applications, Regional Analysis
17 janv. 2023 04h33 HE | Douglas Insights
Douglas, Jan. 17, 2023 (GLOBE NEWSWIRE) -- The pharmaceutical drugs Industry takes the initiative in research, development, production, and the consequent distribution of drugs all over the world....
Dyadic Logo Current.jpg
Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference
04 janv. 2023 08h30 HE | Dyadic International, Inc.
JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
NTTSNew
New to The Street Airs Episode #418, Five Corporate Interviews, Broadcasting on the Fox Business Network, Tonight, Monday, December 19, 2022, at 10:30 PM PT
19 déc. 2022 09h30 HE | FMW Media Works Corp
NEW YORK, Dec. 19, 2022 (GLOBE NEWSWIRE) -- FMW Media’s New to The Street announces the 418th episode of its nationally syndicated TV show, airing tonight, Monday, December 19, 2022, at 10:30 PM PT...
NTTSNew
New to The Street / Newsmax TV Announces Episode #417, Nine Corporate Interviews for this Week's TV Broadcast, Sunday, December 18, 2022, Hour Slot 10-11 AM ET
16 déc. 2022 09h31 HE | FMW Media Works Corp
NEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) -- FMW Media's New To The Street / Newsmax TV announces the broadcasting line-up of its nationally syndicated 1-hour TV show this Sunday, December 18, 2022,...